Scavenger receptor class B type I (SR-BI) is a high-affinity receptor for high-density lipoprotein (HDL). The primary role of this receptor is the selective uptake of HDLs in the liver through reverse cholesterol transport. SR-BI interacts with HDL to regulate lipid metabolism and affects various vascular cell functions involved in atherosclerosis (As). In addition, SR-BI is involved in the development of malignant tumors and infectious diseases. This article reviews the function and potential therapeutic targets of SR-BI in As, malignancies, and infectious diseases.Keywords: Scavenger receptor class B, type I; High-density lipoprotein; Atherosclerosis; Malignant neoplasms Scavenger receptor class B type I (SR-BI) is the first natural membrane receptor for high-density lipoprotein (HDL) at the molecular level. This high-affinity receptor exhibits physiological correlation with HDL. SR-BI is mainly expressed in liver, adrenal, ovarian, and testicular tissues and is also distributed in vascular endothelial cells, smooth muscle cells, macrophages, and adrenal cortical cells. SR-BI is located in the pits on the cell surface and regulates cholesterol in the cell membrane. This protein, with a molecular weight of approximately 82 kDa, contains 509 amino acids. SR-BI contains two short intracellular N-and C-terminal cytoplasmic domains, two transmembrane domains, and one large extracellular domain, which consists of 5 to 6 cysteine residues and multiple N-linked glycosylation sites [1,2]. The extracellular loop of SR-BI can interact with many proteins, especially HDL. The predicted sequences of the SR-BI protein in various mammalian species share 70%-80% sequence homology. The classical role of SR-BI is mediating the selective uptake of HDL-cholesterol esters (CE) in vivo and in vitro by reverse cholesterol transport (RCT) [3]. SR-BI also mediates the two-way flow of unesterified cholesterol and phospholipids between lipoproteins and cells [4]. In the liver, it regulates HDL particle size and composition [5]. Numerous studies have shown that SR-BI plays a crucial role in the prevention of atherosclerosis (As). SR-BI is associated with the development of malignancies and infectious diseases. This article summarizes the role of SR-BI and its potential therapeutic targets in As, malignancies, and infectious diseases.